Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
TriSalus Life Sciences, Inc.
TCR2 Therapeutics
Toray Industries, Inc
Novo Nordisk A/S
Tempest Therapeutics